|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.04 USD | -1.50% |
|
-0.08% | -32.55% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 12.4B 11.81B 10.99B 9.8B 17.44B 1,050B 19.19B 136B 50.66B 430B 46.57B 45.53B 1,849B | P/E ratio 2024 * |
31.4x | P/E ratio 2025 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise value | 11.64B 11.1B 10.32B 9.21B 16.38B 987B 18.03B 128B 47.59B 404B 43.75B 42.77B 1,737B | EV / Sales 2024 * |
4.14x | EV / Sales 2025 * | 3.54x |
| Free-Float |
99.12% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioMarin Pharmaceutical Inc.
More recommendations
More press releases
More news
| 1 day | -1.50% | ||
| 1 week | +1.21% | ||
| Current month | -1.50% | ||
| 1 month | -2.34% | ||
| 3 months | -28.69% | ||
| 6 months | -13.36% | ||
| Current year | -32.55% |
1 week
64.11
66.17
1 month
61.1567.95
Current year
61.1599.25
1 year
61.1599.56
3 years
61.15117.77
5 years
61.15131.95
10 years
61.15151.75
| Director | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 56 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 50 | 2020-01-28 |
C. Guyer
CTO | Chief Tech/Sci/R&D Officer | 62 | 2020-04-30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Elaine Heron
BRD | Director/Board Member | 76 | 2002-06-30 |
Randy Meier
CHM | Chairman | 65 | 2023-11-30 |
David Pyott
BRD | Director/Board Member | 70 | 2016-01-03 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.45% | 1 M€ | -.--% | - | |
| 1.79% | 0 M€ | 0.00% | - | |
| 1.59% | 0 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.50% | +1.21% | -29.63% | -23.03% | 12.58B | ||
| +0.85% | +0.67% | +7.11% | -7.32% | 89B | ||
| -0.41% | +3.96% | +36.57% | +8.98% | 49.64B | ||
| +0.32% | +3.31% | +160.14% | +92.42% | 37.1B | ||
| +2.24% | +4.01% | -30.01% | -28.44% | 23.41B | ||
| -1.81% | +2.12% | +35.58% | +12.75% | 14.37B | ||
| -0.60% | -0.92% | +46.91% | -38.19% | 12.74B | ||
| +7.86% | +3.42% | +265.62% | +425.98% | 10.67B | ||
| +1.19% | +5.39% | -53.76% | -64.28% | 9.71B | ||
| +0.99% | +5.31% | +21.87% | +35.13% | 9.51B | ||
| Average | +0.91% | +2.77% | +46.04% | +41.40% | 26.87B | |
| Weighted average by Cap. | +0.63% | +2.79% | +40.73% | +23.15% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.81B 2.68B 2.49B 2.23B 3.96B 238B 4.36B 30.99B 11.5B 97.73B 10.57B 10.34B 420B | 3.1B 2.95B 2.75B 2.45B 4.36B 263B 4.8B 34.12B 12.67B 108B 11.64B 11.38B 462B |
| Net income | 397M 378M 352M 314M 559M 33.65B 615M 4.37B 1.62B 13.79B 1.49B 1.46B 59.23B | 580M 553M 514M 459M 816M 49.17B 899M 6.39B 2.37B 20.15B 2.18B 2.13B 86.56B |
| Net Debt | -752M -716M -666M -594M -1.06B -63.68B -1.16B -8.27B -3.07B -26.1B -2.82B -2.76B -112B | -1.44B -1.37B -1.27B -1.13B -2.02B -122B -2.22B -15.8B -5.87B -49.84B -5.39B -5.27B -214B |
More financial data
* Estimated data
Employees
3,401
Sector
Pharmaceuticals
Calendar
2024-12-04
- Evercore ISI HealthCONx Conference
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-02 | 65.04 $ | -1.50% | 1,185,197 |
| 24-11-29 | 66.03 $ | +0.93% | 700,252 |
| 24-11-27 | 65.42 $ | +0.83% | 950,545 |
| 24-11-26 | 64.88 $ | -0.32% | 999,740 |
Delayed Quote Nasdaq, December 02, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
65.04USD
Average target price
98.02USD
Spread / Average Target
+50.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMRN Stock